174 related articles for article (PubMed ID: 22761382)
1. Hepatitis C virus-mediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surface.
Kim H; Mazumdar B; Bose SK; Meyer K; Di Bisceglie AM; Hoft DF; Ray R
J Virol; 2012 Sep; 86(18):9919-28. PubMed ID: 22761382
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production.
Saito K; Ait-Goughoulte M; Truscott SM; Meyer K; Blazevic A; Abate G; Ray RB; Hoft DF; Ray R
J Virol; 2008 Apr; 82(7):3320-8. PubMed ID: 18216090
[TBL] [Abstract][Full Text] [Related]
3. Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation.
Landi A; Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
J Viral Hepat; 2011 Oct; 18(10):700-13. PubMed ID: 20701679
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions.
Kang W; Sung PS; Park SH; Yoon S; Chang DY; Kim S; Han KH; Kim JK; Rehermann B; Chwae YJ; Shin EC
Gastroenterology; 2014 May; 146(5):1351-60.e1-4. PubMed ID: 24486950
[TBL] [Abstract][Full Text] [Related]
5. Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.
Yang C; Zhao X; Sun D; Yang L; Chong C; Pan Y; Chi X; Gao Y; Wang M; Shi X; Sun H; Lv J; Gao Y; Zhong J; Niu J; Sun B
Cell Mol Immunol; 2016 Jan; 13(1):94-102. PubMed ID: 25683609
[TBL] [Abstract][Full Text] [Related]
6. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells.
Pierre P; Mellman I
Cell; 1998 Jun; 93(7):1135-45. PubMed ID: 9657147
[TBL] [Abstract][Full Text] [Related]
7. Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.
Ishibashi M; Yamaguchi H; Hirotani Y; Sakurada A; Endo T; Sugitani M; Takayama T; Makishima M; Esumi M
Arch Virol; 2018 Apr; 163(4):855-865. PubMed ID: 29248968
[TBL] [Abstract][Full Text] [Related]
8. Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies.
Wiendl H; Lautwein A; Mitsdörffer M; Krause S; Erfurth S; Wienhold W; Morgalla M; Weber E; Overkleeft HS; Lochmüller H; Melms A; Tolosa E; Driessen C
J Neuroimmunol; 2003 May; 138(1-2):132-43. PubMed ID: 12742663
[TBL] [Abstract][Full Text] [Related]
9. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
[TBL] [Abstract][Full Text] [Related]
10. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation.
Tu Z; Hamalainen-Laanaya HK; Nishitani C; Kuroki Y; Crispe IN; Orloff MS
Int Immunol; 2012 Feb; 24(2):97-106. PubMed ID: 22190574
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells.
Costantino CM; Ploegh HL; Hafler DA
J Immunol; 2009 Jul; 183(2):945-52. PubMed ID: 19553543
[TBL] [Abstract][Full Text] [Related]
12. Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection.
Tomer S; Chawla YK; Duseja A; Arora SK
World J Gastroenterol; 2016 Jun; 22(22):5173-82. PubMed ID: 27298560
[TBL] [Abstract][Full Text] [Related]
13. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.
Brownell J; Wagoner J; Lovelace ES; Thirstrup D; Mohar I; Smith W; Giugliano S; Li K; Crispe IN; Rosen HR; Polyak SJ
J Hepatol; 2013 Oct; 59(4):701-8. PubMed ID: 23770038
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus present in the sera of infected patients interferes with the autophagic process of monocytes impairing their in-vitro differentiation into dendritic cells.
Granato M; Lacconi V; Peddis M; Di Renzo L; Valia S; Rivanera D; Antonelli G; Frati L; Faggioni A; Cirone M
Biochim Biophys Acta; 2014 Jul; 1843(7):1348-55. PubMed ID: 24726834
[TBL] [Abstract][Full Text] [Related]
15. Understanding the biological context of NS5A-host interactions in HCV infection: a network-based approach.
Tripathi LP; Kambara H; Chen YA; Nishimura Y; Moriishi K; Okamoto T; Morita E; Abe T; Mori Y; Matsuura Y; Mizuguchi K
J Proteome Res; 2013 Jun; 12(6):2537-51. PubMed ID: 23682656
[TBL] [Abstract][Full Text] [Related]
16. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.
Shi GP; Bryant RA; Riese R; Verhelst S; Driessen C; Li Z; Bromme D; Ploegh HL; Chapman HA
J Exp Med; 2000 Apr; 191(7):1177-86. PubMed ID: 10748235
[TBL] [Abstract][Full Text] [Related]
17. Role of A20 in interferon-α-mediated functional restoration of myeloid dendritic cells in patients with chronic hepatitis C.
Ma L; Zhou Y; Zhang Y; Li Y; Guo Y; He Y; Wang J; Lian J; Hao C; Moorman JP; Yao ZQ; Zhou Y; Jia Z
Immunology; 2014 Dec; 143(4):670-8. PubMed ID: 24965710
[TBL] [Abstract][Full Text] [Related]
18. Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment.
Maubach G; Lim MC; Kumar S; Zhuo L
Biochim Biophys Acta; 2007 Feb; 1773(2):219-31. PubMed ID: 17178165
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial).
Chernykh E; Leplina O; Oleynik E; Tikhonova M; Tyrinova T; Starostina N; Ostanin A
Immunol Res; 2018 Feb; 66(1):31-43. PubMed ID: 29164490
[TBL] [Abstract][Full Text] [Related]
20. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
